Metastatic Breast Cancer Clinical Trials in Stockholm
2 recruitingStockholm, Sweden
Showing 1–2 of 2 trials
Recruiting
DESTINY Breast Respond HER2-low Europe
Metastatic Breast CancerUnresectable Breast CancerHER2-low Expressing Breast Cancer
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1,155 enrolled211 locationsNCT05945732
Recruiting
Phase 1
A First-in-Human Phase 1 Safety and Biodistribution of [177Lu]Lu-ABY-271 in Subjects With HER2-positive Metastatic Breast Cancer
Metastatic Breast CancerHER2 + Breast Cancer
Affibody21 enrolled3 locationsNCT07081555